--- title: "Diabetic Eye Exam Recall: Closing the Annual Screening Gap" description: "Only 64.8% of US adults with diabetes report an annual eye exam, short of the federal target — why the exam lapses, and what a recall protocol actually…" url: https://www.getarbol.com/en/blog/diabetic-eye-exam-recall-us/ lang: en --- # Diabetic Eye Exam Recall: Closing the Annual Screening Gap Only 64.8% of US adults with diabetes report an annual eye exam, short of the federal target — why the exam lapses, and what a recall protocol actually fixes. [**Veronica Tobon** Medical Advisor, Clínica Sierra Vista](https://www.getarbol.com/en/blog/authors/veronica-tobon/) July 25, 2026 7 min read Only 64.8% of US adults with diagnosed diabetes reported having a dilated eye exam in the past 12 months, short of the federal [Healthy People 2030 target of 70.3%](https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/diabetes/increase-proportion-adults-diabetes-who-have-yearly-eye-exam-d-04). That gap is not a knowledge problem — clinicians and patients both know the exam is recommended. It is a tracking problem: the exam usually happens outside the practice that manages the diabetes, and without a system to confirm who went and who didn’t, a meaningful share of patients simply never complete it. ## The annual eye exam is standard of care, and vision loss is the price of skipping it Diabetic retinopathy is [the leading cause of new blindness among working-age adults in the United States](https://www.aao.org/eyenet/article/diabetic-retinopathy-screening-treatment-trends), and it typically causes no symptoms until damage is already advanced — which is exactly why screening, not symptom-driven care, is the standard. An estimated 9.6 million Americans have some degree of diabetic retinopathy, roughly one in four people with diabetes, and about 1.8 million have vision-threatening disease that needs prompt treatment to prevent permanent vision loss. The screening interval is not a vague suggestion. The [American Diabetes Association’s Standards of Care in Diabetes—2026](https://diabetesjournals.org/care/article/49/Supplement_1/S261/163919/12-Retinopathy-Neuropathy-and-Foot-Care-Standards) sets it out precisely: people with type 2 diabetes should get an initial dilated, comprehensive eye exam at the time of diagnosis; people with type 1 diabetes should get one five years after onset. After that, if one or more annual exams show no retinopathy and glycemic control is at goal, the interval can stretch to every 1–2 years — but if any level of retinopathy is present, the exam is repeated at least annually. The guideline builds in a shorter leash for exactly the patients who need it most, which only works if someone is actually tracking who falls into which category. ## Nationally, completion falls short of the guideline — and further short for some patients Guideline vs. reality Annual diabetic eye exam completion vs. the national target had an eye exam in the past 12 months: 65% (meta 70%) Meta: 70% Fuente: HHS Office of Disease Prevention and Health Promotion, Healthy People 2030 The national average also hides how uneven completion is. The American Academy of Ophthalmology’s own analysis puts it bluntly: “only about half” of patients who should be screened routinely are, and the rate splits further by race and ethnicity — 55.6% for non-Hispanic White patients with diabetes, versus 48.9% for Black patients and 48.2% for Hispanic patients. A practice that only looks at its overall completion number can miss that the shortfall is concentrated in a specific slice of its own patient panel. What's actually at stake Diabetic retinopathy is common, and largely preventable blindness 9.6M Americans have diabetic retinopathy — about 1 in 4 people with diabetes AAO EyeNet 1.8M have vision-threatening disease, roughly 5% of people with diabetes AAO EyeNet 48.2%–55.6% Annual exam completion by race/ethnicity — Hispanic and Black patients screen lowest AAO EyeNet ## The gap opens when the exam lives outside the practice managing the diabetes Most primary care and endocrinology practices don’t have an ophthalmologist or optometrist on-site, so the annual eye exam is typically a referral out — and a referral is where visibility ends for most scheduling systems. The practice sends the order, but there is often no routine mechanism that closes the loop: no automatic flag when the referral isn’t scheduled, no follow-up when the patient never shows, and no easy way to tell “referred” apart from “screened” inside the chart. This is not a small structural quirk. One study modeling the [supply side found that type 2 diabetes prevalence in US adults is expected to grow by roughly 50% by 2025, while the number of practicing optometrists and ophthalmologists is projected to grow only 1–2%](https://pmc.ncbi.nlm.nih.gov/articles/PMC11060615/) over the same period — meaning even a perfectly executed referral increasingly lands on a system with less capacity to absorb it. In a purely referral-based model with no active follow-up, one primary care study measured adherence to the recommended annual exam at just 18.7% at twelve months. That is close to the same order of magnitude as the disparities noted above, and it is consistent with what practices tracking Medicare quality measures already see in [Annual Wellness Visit](https://www.getarbol.com/en/blog/medicare-annual-wellness-visit/) gap-closure work more broadly: a preventive service that depends on the patient independently completing a second appointment, at a second location, tends to fall through unless someone owns confirming it happened. ## A recall protocol — not a stronger referral — closes the gap The evidence on what actually moves the adherence number is specific, and it isn’t “send a stronger referral letter.” In the primary care study cited above, adding automated retinal imaging at the point of care, giving patients their results immediately, and following up by phone within two weeks of an incomplete screening raised adherence from 18.7% to 55.4% at twelve months — nearly a threefold increase. One clinic's before-and-after Eye-exam adherence with and without an active recall step Adherence at 12 months Fuente: Primary-care implementation study, PubMed Central Other implementations point the same direction at smaller scale. A primary care clinic that added mobile retinal screening plus an EMR-based tracking dashboard — logging completion dates and surfacing them on a quality metric view — raised its average screening rate from 45.3% to 52.1% over five months. A [teleretinal screening program across several community health centers](https://pmc.ncbi.nlm.nih.gov/articles/PMC11863591/) with baseline compliance ranging from 25% to 40% increased compliance by an average of 7.2 percentage points once it was running. None of these interventions changed the guideline or the patient’s motivation — they changed whether the practice could actually see, in real time, who was due and who had completed the exam. That same tracking-over-relying-on-memory logic shows up in how practices handle other chronic-disease recall gaps, including the routine screening bundled into [chronic disease management](https://www.getarbol.com/en/blog/glp1-coverage-primary-care/) more broadly and the reminder cadence built around [Medicare Annual Wellness Visits](https://www.getarbol.com/en/blog/awv-gap-closure-without-nagging/) — the mechanism that works is the same regardless of which specific test or visit it’s chasing. What this doesn't mean None of this argues for screening more often than the guideline calls for. A patient with clear prior exams and glycemic control at goal genuinely qualifies for the 1–2 year interval under the ADA’s own recommendation — the fix is closing the gap for the exam that’s actually due, not defaulting everyone to annual regardless of risk. ## Building the recall protocol: what your practice can do this week Building the recall protocol this month - Pull every patient currently overdue for their guideline interval Annual if any level of retinopathy is on record; every 1–2 years only if prior exams were clear and glycemic control is at goal (ADA Standards of Care, Rec. 12.5). - Track completion, not just the referral order A referral sent is not a screening done. Log the date the result actually comes back into the chart, and flag anyone with no result after a set window. - Follow up by phone within two weeks of a missed or unconfirmed referral Active phone outreach, not a single portal message, is the step that moved adherence from 18.7% to 55.4% in the primary-care study above. - Auto-flag any retinopathy-positive result for annual recall Per ADA guidance, any level of diabetic retinopathy resets the patient to at least a once-a-year exam, regardless of what the standard interval would otherwise be. - If referral capacity is the real bottleneck, evaluate in-house retinal imaging Eye-care provider supply is projected to grow only 1–2% while type 2 diabetes prevalence grows an estimated 50% by 2025 — referring out alone won't scale with demand. A practice does not need to become an eye-care provider to close this gap; it needs a way to know, for every patient with diabetes, whether the annual exam happened — and a standing process for reaching out again when it hasn’t. If your practice serves patients across the US more broadly and is working through this kind of chronic-disease recall gap, [see how Arbol supports US practices](https://www.getarbol.com/en/united-states/). Disclaimer This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. ## More to read - Practice operations Jul 25, 2026 ### [Urgent care walk-in vs. scheduled access with overflow handling](https://www.getarbol.com/en/blog/urgent-care-walkin-vs-scheduled-line-us/) Urgent care visits keep growing, but a scheduled line with overflow handling protects continuity. An honest compare, with a clear verdict for US practices. 10 min read Tomas Giraldo - Mental health Jul 26, 2026 ### [The hidden gap between a positive PHQ-9 and treatment](https://www.getarbol.com/en/blog/phq9-followup-primary-care-us/) Positive PHQ-9 screens are not treatment. Peer-reviewed US data show up to 30% get no documented follow-up, and few practices track their own rate. 10 min read David Lara - Practice operations Jul 27, 2026 ### [Flu, RSV, and COVID Peak Together. Is Your Front Desk Ready?](https://www.getarbol.com/en/blog/fall-respiratory-season-capacity-us/) CDC's own season outlook shows flu, RSV, and COVID converge into one hospitalization peak every winter — the planning window closes before phones start ringing. 10 min read Samuel Giraldo ## Every call answered. Every appointment in its place. Arbol answers calls and WhatsApp 24/7, and books and confirms appointments on top of the medical record and systems you already use. [Book a demo](https://cal.com/tomas-giraldo-pdfbl9/30-min-arbol-ai-demo) --- **Arbol AI** — AI agents for clinics and healthcare providers: they answer and reach patients by phone, WhatsApp, SMS, email and web chat, book their appointments 24/7 and keep a record of every conversation. - Original page: - Book a demo: · Pricing: - Agent index: · Support: